Scholarlink

Purpose <p>Oncological exercise therapy (OET) can enhance physical function and psychosocial well-being of cancer patients. Despite this, OET is still not routinely implemented in cancer care. To address this gap, our study analyzes cancer patients’ perspectives on facilitators and barriers for OET participation.</p> Methods <p>This qualitative study employed semi-structured focus groups and was conducted within the IMPLEMENT research consortium. Focus groups were audio-recorded, transcribed verbatim, and analyzed using framework analysis.</p> Results <p>Thirty cancer patients (mean age 57 ± 7&#xa0;years; 53% women) participated, and most were diagnosed with breast cancer (20%), lymphoma or leukemia (20%), or pancreatic cancer (13%). Participants reported being motivated to become physically active, even when no OET was available. However, they received limited information about physical activity (PA), specifically about OET. They also felt there was a lack of OET offers from healthcare providers. Participation could be increased by improved accessibility involving informational and structural factors, fostering adherence by higher perceived safety and self-efficacy, and by providing individually tailored and low-threshold information for patients.</p> Conclusion <p>OET could be a valuable opportunity to support patients throughout their cancer trajectory. To increase participation and promote PA uptake, individually tailored support should be provided in terms of personalized guidance by healthcare practitioners and easily accessible OET offers.</p> Trial registration <p>German Clinical Trial Register (Deutsches Register Klinischer Studien—DRKS 00032292), registered 19/07/2023. Clinical Trials Registry (NCT06496711), registered 22/05/2024. Bavarian Cancer Research Center (Bayerisches Krebsforschungszentrum (BZKF) DZ-2024–2165-9), registered 07/06/2024.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

A qualitative analysis of cancer patients’ views on facilitators and barriers for the implementation of oncological exercise therapy

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月14日

查看全文
  • Dominik Morlok,
  • Jana Rüter,
  • Mona Illmann,
  • Laura Bieniosek,
  • Christine Welker,
  • Melanie Reitz,
  • Janina Meuer,
  • Thomas Okon,
  • Hansjörg Baurecht,
  • Wolfgang Herr,
  • Tobias Pukrop,
  • Mirko Brandes,
  • Anika Berling-Ernst,
  • Louisa Sell,
  • Wiebke Jensen,
  • Rebecca Zimmer,
  • Heike Schmidt,
  • Florian Wagemann,
  • Renee Stark,
  • Annalena Kleinhenz,
  • Bernardine Madl,
  • Hajo Zeeb,
  • Michael Leitzmann,
  • Freerk T. Baumann,
  • Anne Herrmann

摘要

Purpose

Oncological exercise therapy (OET) can enhance physical function and psychosocial well-being of cancer patients. Despite this, OET is still not routinely implemented in cancer care. To address this gap, our study analyzes cancer patients’ perspectives on facilitators and barriers for OET participation.

Methods

This qualitative study employed semi-structured focus groups and was conducted within the IMPLEMENT research consortium. Focus groups were audio-recorded, transcribed verbatim, and analyzed using framework analysis.

Results

Thirty cancer patients (mean age 57 ± 7 years; 53% women) participated, and most were diagnosed with breast cancer (20%), lymphoma or leukemia (20%), or pancreatic cancer (13%). Participants reported being motivated to become physically active, even when no OET was available. However, they received limited information about physical activity (PA), specifically about OET. They also felt there was a lack of OET offers from healthcare providers. Participation could be increased by improved accessibility involving informational and structural factors, fostering adherence by higher perceived safety and self-efficacy, and by providing individually tailored and low-threshold information for patients.

Conclusion

OET could be a valuable opportunity to support patients throughout their cancer trajectory. To increase participation and promote PA uptake, individually tailored support should be provided in terms of personalized guidance by healthcare practitioners and easily accessible OET offers.

Trial registration

German Clinical Trial Register (Deutsches Register Klinischer Studien—DRKS 00032292), registered 19/07/2023. Clinical Trials Registry (NCT06496711), registered 22/05/2024. Bavarian Cancer Research Center (Bayerisches Krebsforschungszentrum (BZKF) DZ-2024–2165-9), registered 07/06/2024.